ESOPAug 7, 2026, 04:07 PM
Spyre Therapeutics Grants Equity Inducement Awards to 4 Employees
AI Summary
Spyre Therapeutics, Inc. announced that its independent Compensation Committee approved the grant of equity inducement awards to four non-executive employees. These awards include 19,436 stock options and 6,186 restricted stock units (RSUs) under the company's 2018 Equity Inducement Plan. The grants were material to the employees' acceptance of employment and comply with Nasdaq Listing Rule 5635(c)(4).
Key Highlights
- Granted 19,436 stock options to four non-executive employees.
- Granted 6,186 restricted stock units (RSUs) to four non-executive employees.
- Awards are inducement grants under the 2018 Equity Inducement Plan.
- Stock options have an exercise price of $94.93 per share.
- Options vest 1/4th on first anniversary, then 1/48th monthly.
- RSUs vest 1/4th on each anniversary of specific quarterly dates.
Price Impact
More from SYRE